CompletedNot Applicable

Study of HIV, HCV, APS and Phylogenetics for PWID

Kenya4,301 participantsStarted 2018-02-26

Plain-language summary

This study will determine whether assisted partner notification services (APS) can identify and link to care, the sexual and needle-sharing partners of HIV-infected and HIV/hepatitis C (HCV) co-infected persons who inject drugs (PWID). It will also define the risk factors for onward HIV and HCV transmission among PWID using viral phylogenetics.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \> or = 18 years of age * Active intravenous drug use (IDU) as defined by injecting at least twice in the past month * Willing and able to provide informed consent * HIV infected (either new diagnosis or known diagnosis) * Willing and able to provide locator information for sexual and/or injecting partners Exclusion Criteria: • Classified as at high risk for IPV\* \*Participants will be classified as at moderate risk for IPV if they report 1) history of IPV during their lifetime either from a current or past partner; and/or 2) fear of IPV if they participate in the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Sexual partners tested

Timeframe: 4 years

Injecting partners tested

Timeframe: 4 years

Partners diagnosed with HIV and HCV

Timeframe: 4 years

HIV-infected partners linked to HIV care

Timeframe: 4 years

HCV-infected partners linked to HCV care

Timeframe: 4 years

Index participants linked to HIV and HCV care

Timeframe: 4 years

Trial details

NCT IDNCT03447210

SponsorUniversity of Washington

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-02-28

View on ClinicalTrials.gov More HIV/AIDS trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Sexual partners tested

Timeframe: 4 years

Injecting partners tested

Timeframe: 4 years

Partners diagnosed with HIV and HCV

Timeframe: 4 years

HIV-infected partners linked to HIV care

Timeframe: 4 years

HCV-infected partners linked to HCV care

Timeframe: 4 years

Index participants linked to HIV and HCV care

Timeframe: 4 years